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Abstract
Introduction: The aim of the study was to evaluate exercise capacity using
cardiopulmonary exercise test (CpET) and serum B-type natriuretic peptide (BNP)
levels in patients with single or systemic right ventricles.
Material and methods: The study group included 40 patients (16 males) 
– 17 with transposition of the great arteries after Senning operation, 13 with
corrected transposition of the great arteries and 10 with single ventricle after
Fontan operation, aged 19-55 years (mean 28.8 ±9.5 years). The control group
included 22 healthy individuals (10 males) aged 23-49 years (mean 30.6 ±6.1 years).
Results: The majority of patients reported good exercise tolerance – accordingly
27 were classified in NYHA class I (67.5%), 12 (30%) in class II, and only 1 (0.5%)
in class III. Cardiopulmonary exercise test revealed significantly lower exercise
capacity in study patients than in control subjects. In the study vs. control group
VO2max was 21.7 ±5.9 vs. 34.2 ±7.4 ml/kg/min (p = 0.00001), maximum heart
rate at peak exercise (HRmax) 152.5 ±32.3 vs. 187.2 ±15.6 bpm (p = 0.00001),
VE/VCO2 slope 34.8 ±7.1 vs. 25.7 ±3.2 (p = 0.00001), forced vital capacity (FVC)
3.7 ±0.9l vs. 4.6 ±0.3 (p = 0.03), forced expiratory volume in 1 s (FEV1) 
3.0 ±0.7 vs. 3.7 ±0.9l (p = 0.0002) respectively. Serum BNP concentrations were
higher in study patients than in control subjects; 71.8 ±74.4 vs. 10.7 ±8.1 (pg/ml)
respectively (p = 0.00001). No significant correlations between BNP levels and
CpET parameters were found. 
Conclusions: Patients with a morphological right ventricle serving the systemic
circulation and those with common ventricle physiology after Fontan operation
show markedly reduced exercise capacity. They are also characterized by higher
serum BNP concentrations, which do not however correlate with CpET
parameters.
Key words: B-type natriuretic peptide, heart failure, grown up congenital heart
disease, common ventricle, Senning/Mustard operation, Fontan operation.
Introduction 
Patients with transposition of the great arteries after Senning/Mustard
operation (TGA), those with corrected transposition of the great arteries
(CCTGA) in whom a morphological right ventricle serves the systemic
circulation and patients with common ventricular physiology after Fontan
operation share special haemodynamic characteristics. The morphological
right ventricle faces systemic circulation resistance, and thus works under
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higher pressure afterload [1-6]. Single ventricle
function in survivors of Fontan operation is highly
dependent upon preload [7-9]. In these two clinical
scenarios atrioventricular valve incompetence
increasing during exercise leads to higher volume
load of ventricles [9, 10]. As a result such patients
often develop heart failure [4, 5, 9, 10-14]. Adult
patients with congenital heart disease (CHD), due
to long-term adaptation, usually self-assess their
exercise tolerance as satisfactory [15-19]. Objective
evaluation of exercise capacity in such patients is
of key importance since the introduction of
appropriate treatment during the asymptomatic
phase may improve outcomes in terms of heart
failure symptoms, hospitalizations and mortality.
The cardiopulmonary exercise test is a validated
diagnostic and prognostic tool both in patients with
left ventricular heart failure [20] and in those with
selected CHD [15, 21-26]. Similar diagnostic and
prognostic value of serum B-type natriuretic peptide
(BNP) concentrations has been documented [20],
including in adult patients with CHD in whom left [16,
27-29] or right ventricular [17, 18, 21, 30-34] function
is impaired as a result of pressure or volume overload.
However, we are not aware of any reports on relations
between BNP levels and exercise capacity measured
with the cardiopulmonary exercise test in a specific
population of patients with a morphological right
ventricle serving the systemic circulation or common
ventricular physiology after Fontan operation. 
The study aimed to evaluate exercise capacity
using the cardiopulmonary exercise test in adult
patients with a morphological right ventricle or
single ventricle serving the systemic circulation,
and levels of serum BNP in these patients, and to
determine the relationship between BNP
concentrations and cardiopulmonary exercise test
parameters.
Material and methods
Patients
The study group included 40 patients (16 males)
– 17 with transposition of the great arteries after
Senning operation (TGA), 13 with corrected
transposition of the great arteries (CCTGA) and 
10 with a common ventricle after Fontan operation,
aged 19-55 years (mean 28.8 ±9.5 years). TGA
patients were operated on at the age of 1-14 years
(mean 4.3 ±3.7 years), 18-30 years earlier (mean
21.6 ±4.2 years); 2 of them presented with small
interatrial shunts. Of those with CCTGA 3 patients
were operated on at the age of 11-33 years (mean
20.7 ±11.2 years); in 1 a ventricular septal defect
(VSD) was closed and tricuspid valvuloplasty was
done, in another an atrial septal defect (ASD) was
closed and the tricuspid valve was replaced with
a mechanical prosthesis, and in the third both an
ASD and VSD were closed and tricuspid
valvuloplasty was carried out. The only other
accompanying abnormality, found in 3 CCTGA
subjects, was right ventricular outflow tract
obstruction with pressure gradients not exceeding
50 mm Hg. Fontan operations in patients with
common ventricular physiology were performed in
subjects at the age of 5-14 years (mean 9.5 ±3.1
years), in all cases adopting the method of right
atrial to pulmonary artery connections (Table I).
Arterial blood oxygen saturation was 84-99% (mean
95.2 ±5.0%) in the entire study group. The control
group included 22 healthy individuals (10 males)
aged 23-49 years (mean 30.6 ±6.1 years). NYHA
functional class was determined by a physician
based on the assessment of patient’s self-reported
symptoms at the time of the exercise test. All study
patients had sinus rhythm (subjects with atrial
fibrillation/flutter were excluded), were free from
arrhythmia and pulmonary disease and had serum
creatine levels less than 140 µg/ml and glutamic
oxaloacetic transaminase activity not exceeding
twice the upper limit of normal. 
Measurement of serum BNP concentrations
In all patients blood samples were drawn from
an antecubital vein prior to the exercise test after
a 15 min rest in supine position. Serum B-type
natriuretic peptide concentrations were determined
using immunoradiometric assay kit – Shionoria BNP
(Schering CIS bio international). The radioactivity
was measured for 1 min with gamma scintillation
counter type NZ 335.
Congenital  Number of  Gender Age Number ofA g e of NYHA
heart  patients % male [years] treated patients operation class
disease [years] I/II/III
TGA-Senning 17 7 (41%) 26.1 ±4.9 17 (100%) 4.3 ±3.7 15/2/0
CCTGA 13 6 (46%) 36.2 ±12.1 3 (23%) 20.7 ±11.2 6/7/0
Fontan 10 3 (33%) 23.8 ±3.1 10 (100%) 9.5 ±3.1 6/3/1
TGA-Senning – transposition of the great arteries after Senning operation, CCTGA – corrected transposition of the great arteries, Fontan – common
ventricle after Fontan operation
Table I. Demographic and clinical characteristics of analysed group of patients
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Cardiopulmonary exercise test
In all study patients a maximum, symptom-limited
(fatigue and/or dyspnoea) treadmill exercise test
according to modified Bruce protocol was performed
(standard Bruce protocol with stage 0 added – 3 min
at 1.7 km/h, 5% grading), whereas in control subjects
standard Bruce protocol was used. Patients were
encouraged to continue walking for as long as their
respiratory quotient (RQ) exceeded 1. The peak
oxygen consumption (peak VO2), carbon dioxide
production (VCO2), and minute ventilation (VE) were
measured using breath-by-breath gas analysis
(Sensor Medics, model Vmax29). Before each test
the system was calibrated with a standardized gas
mixture. A standard 12-lead electrocardiogram was
continuously recorded. Blood pressure was measured
every 2 min using a cuff sphygmomanometer. Peak
VO2 represents an average value measured during
the last 20 s of exercise, and is expressed as
ml/kg/min, ml/min, and the percentage of predicted
peak oxygen consumption. The ventilation/carbon
dioxide slope (VE/VCO2 slope) was calculated
automatically by the computer system of Vmax29.
A spirometric study was performed in all subjects
before the cardiopulmonary exercise test, providing
measurement of forced vital capacity (FVC) and
forced expiratory volume in 1 s (FEV1), which were
expressed as percentage of predicted normal values
adjusting for age, sex and body mass. The evaluation
of the cardiopulmonary exercise tests was performed
by investigators blinded to the results of BNP
measurements.
Statistical analysis
Continuous variables following a normal
distribution were expressed as mean and standard
deviation, those not normally distributed as median
and range. Variables following a normal distribution
were compared using Student’s t-test for unpaired
samples. Otherwise the Mann-Whitney U test was
used. For comparisons involving more than two
groups ANOVA with Tukey post-hoc test following
Shapiro-Wilk test for normality and Leven’s test for
homogeneity of variance or Kruskal-Wallis test with
Dunn’s multiple comparisons test were used.
To assess the degree of correlation between
variables, Spearman’s rank correlation or Pearson’s
correlation coefficient (depending on variable
distribution) was used. Results are presented as the
coefficient of correlation (r). P value < 0.05 was
considered significant. Statistical analysis was
carried out using Statistica software ver. 8. 
Informed consent was obtained from each
patient and the study protocol conforms to the
ethical guidelines of the 1975 Declaration of Helsinki
as reflected in a priori approval of the institution’s
human research committee.
Results
The majority of patients, 27 (67.5%), self-
reported their exercise capacity as satisfactory
and accordingly were classified as NYHA class I;  
12 patients (30%) reported mild intolerance of
exercise and were classified as NYHA class II; 
and only 1 patient (0.5%) after Fontan operation
presented with symptoms of heart failure 
class III. 
Heart failure symptoms were observed in 2 pa  -
tients (12%) with TGA, 7 (54%) with CCTGA, and 
4 (40%) with a single ventricle following Fontan
surgery. 
Cardiopulmonary exercise test parameters
As shown in Table II, the peak VO2 was lower in
the study group than in the control group 
(p = 0.00001). Maximum heart rate at peak exercise
(HRmax) was also lower in the study group than in
healthy individuals (p = 0.00001, Table II).
A significant difference was also observed for the
respiratory workload parameter VE/VCO2 slope,
which was higher in the study group vs. the control
group (p = 0.00001, Table II). Among studied
patients the systolic blood pressure at peak exercise
was lower than in the control group (p = 0.04, 
Table II). Main respiratory quotient (RQ) in the
Study group Control groupV alue of 
N = 40 N = 22 p
Age [years] 28.8 ±9.5 30.3 ±6.1 0.06
BNP [pg/ml] 71.8 ±74.4 10.7 ±8.1 0.00001
VO2 21.7 ±5.9 34.1 ±7.2 0.00001
[ml/kg/min]
VO2% 54.7 ±11.3 89.5 ±15.7 0.00001
VE/VCO2 34.8 ±7.1 25.7 ±3.2 0.00001
HR max  152.5 ±32.3 187.2 ±15.6 0.00001
[bpm]
HR max % 80.9 ±16.3 97.8 ±7.7 0.00005
FVC [l] 3.7 ±0.9 4.6 ±0.3 0.03
FVC % 95.5 ±14.4 104.3 ±9.4 0.04
FEV1 [l] 3.0 ±0.7 3.7 ±0.9 0.04
FEV1% 79.8 ±29.9 98.1 ±12.4 0.0002
BP max  161.5 ±20.3 174.6 ±12.3 0.04
[mm Hg]
RQ 1.0 ±0.04 1.1 ±0.06 0.0005
BNP – brain natriuretic peptide, VO2 – peak oxygen consumption,
VE/VCO2 slope – ventilatory equivalent for carbon dioxide, FVC – forced
vital capacity, FEV1 – forced expiratory volume in 1 s, BP max – peak
exercise blood pressure, HR max – peak exercise heart rate, 
RQ – respiratory quotient
Table II. Comparison of BNP levels and spiroergometric
parameters between studied group of patients and
control group
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Exercise capacity in patients with single ventricle
analysed patients was significantly lower than in
the control group (p = 0.0005, Table II).
Spirometric study
Parameters of pulmonary elasticity FVC and
FVC% were significantly lower in patients with
analysed congenital heart disease than in healthy
controls (p = 0.03, p = 0.04 respectively, Table II).
Moreover, FEV and FEV1%, reflecting airway
obstruction, were also significantly reduced in study
patients compared to healthy subjects (p = 0.04
and p = 0.0002; respectively, Table II).
Mean BNP level was higher in study patients
than in the control group (p = 0.00001, Table II). 
No correlations were found between BNP
concentrations and results of cardiopulmonary
exercise tests, age of the patients at the time of
CHD surgical correction or current age. In NYHA
class I patients mean BNP level of 13.5 ±8.6 pg/ml
was significantly lower than 145.1 ±86.3 pg/ml in
NYHA class II patients (p = 0.00001), but similar to
that in healthy controls (10.9 ±8.2 pg/ml).
Discussion
Most study patients with a morphological RV
serving the systemic circulation and those after
Fontan operation were asymptomatic; only one
third of them reported moderate exercise
intolerance. The European Heart Survey, a large
European registry including adult patients with
congenital heart disease [19], reports similar results
in patients with a morphological right ventricle
serving the systemic circulation and worse exercise
tolerance in patients with common ventricle
physiology after Fontan operation, which is reduced
in 60% of them. Better exercise capacity than in
our study is reported occasionally in patients with
atrial switch operated TGA and CCTGA [30].
However, long-term follow-up studies reveal that
by the 4th decade of life over 50% of patients with
CCTGA develop heart failure [1, 2], and 25-88.5% of
patients 25 years after Senning/Mustard operation
for TGA present severe heart failure symptoms [4,
5]. Our results are similar to those of Piran et al. [8],
who reported symptoms of heart failure in 22% of
atrial switch operated TGA patients, 32% of patients
with CCTGA and 40% of patients after Fontan
operation. Cardiopulmonary exercise test, providing
objective assessment of exercise capacity, revealed
its significant reduction in study patients.
A discrepancy between favourable self-reported
tolerance of exercise and reliable measures of
exercise capacity resulting from long-term
adaptation in such patients, similar to that observed
in other types of congenital heart disease, has been
reported previously by our team [16-18, 35], as well
as by other investigators [15]. The main cause of
heart failure in study patients appears to be
dysfunction of a morphological right ventricle
serving the systemic circulation. Using contrast-
enhanced magnetic resonance imaging Giardii et
al. [24] documented structural and functional RV
abnormalities in patients with CCTGA and atrial
switch operated TGA subjects. They observed
extensive fibrosis resulting most likely from
inadequate perfusion of hypertrophic myocardium
and probably also from insufficient myocardial
protection during cardiac surgery in the past. These
myocardial changes lead to reduced contractility of
a morphological RV serving the systemic circulation.
Patients with a common ventricle after Fontan
operation have diminished cardiac output despite
having only marginal ventricular dysfunction, which
is mainly due to the absence of the pulmonary
ventricle [9]. In patients with a morphological right
ventricle or single ventricle serving the systemic
circulation, atrioventricular valve incompetence
increasing during exercise leads to significant
volume overload of ventricles [2, 8, 9, 35]. Cardiac
output in patients after Mustard/Senning operation
for TGA and especially in patients after Fontan
operation is highly dependent on preload. In the
former situation it is mainly the result of low atrial
buffalo compliance [4, 10]. In the latter one passive
ventricular filling depends on venous pressure 
[7, 11].
Our study, consistently with results reported by
other investigators [15, 23, 36, 37], confirmed the
significant role of pulmonary dysfunction in the
development of heart failure in adult patients with
CHD. Patients in our study presented with
spirometric abnormalities consistent with impaired
pulmonary elasticity as well as airway obstruction
resulting most likely from prior surgery with lung
scarring, diaphragmatic palsy, atelectasis and
cardiomegaly [15, 36, 37]. 
We have shown that in patients with
a morphological right ventricle serving the systemic
circulation and common ventricle physiology after
Fontan operation maximal heart rate at peak
exercise is reduced as compared to healthy adults.
Similar observations in patients with CCTGA were
made by Friedriksen et al. [37], and by Nozori et al.
[26] in an unselected group of adult patients with
congenital heart disease of whom many underwent
Mustard/Senning operation for TGA. However, this
was not confirmed by Canadian investigators [30].
According to Gillian et al. [6] lower heart rate at
peak exercise in patients with TGA after atrial
switch operation may represent an adaptive
mechanism facilitating ventricular filling via
noncompliant atrial buffalo. Similar observations
suggesting clinical relevance of an impaired
chronotropic response in adult heart failure patients
with congenital heart disease have been reportedby others [15, 23, 26]. A team of investigators from
Royal Brompton Hospital [37] has shown
chronotropic incompetence to be a risk factor of
death in such patients [38]. Finding that 15 patients
(37.5% of the study group) failed to reach 80%
maximum predicted age-adjusted heart rate at
peak exercise, which is believed to worsen the
prognosis, may reflect potential risks in our study
population [38]. This rate is similar to that reported
by Norozi et al. [26], who studied a group including
patients with complex cyanotic heart disease and
those with Fontan physiology, but still significantly
higher than in patients with ischaemic heart
disease (11%) or dilated cardiomyopathy (25%) [39]. 
Another diagnostic and prognostic factor in heart
failure is B-type natriuretic peptide [1, 20, 21, 33].
We have found significantly increased serum
concentrations of BNP in patients with
a morphological RV serving the systemic circulation
and in those after Fontan operation. Similar findings
were reported by Laarsen et al. [40]. Higher BNP
levels were also documented in patients with
a right ventricle serving the systemic circulation in
a population including many subjects with CCTGA,
atrial switch operated TGA and after Fontan
operation [29]. Limited reports on BNP levels in
patients with common ventricle physiology after
Fontan operation are inconsistent. Ohuhi et al. [14]
found increased concentrations of BNP only in
symptomatic patients, especially in subjects
operated on using atrio-pulmonary connection,
presenting with a markedly enlarged right atrium,
where natriuretic peptide is produced. Of  note, all
patients after Fontan operation in our study were
survivors of such procedures. Increased serum BNP
levels in patients after Fontan operation were
reported by Inai et al. [9]. Like us, they also did not
find a significant correlation between BNP
concentration and peak oxygen uptake during
cardiopulmonary exercise testing. They also failed
to provide evidence for a prognostic role of serum
BNP level during 4-year follow-up. In contrast, Law
et al. [27] did not find a significant increase of serum
BNP levels in patients after Fontan operation 
who presented with clinical symptoms and
haemodynamic evidence of heart failure. Such
equivocal findings on BNP levels probably result
from complex pathophysiology of heart failure in
the studied patients. Although, as reported by
others, BNP concentrations were higher in patients
in more advanced NYHA functional classes [23, 29,
40], they did not correlate with results of
cardiopulmonary exercise testing. BNP release has
been documented to be mainly dependent upon
myocardial wall stress resulting from pressure and
volume overload [16-18, 21, 27-29, 30-34]. In study
patients reduced preload, attenuating BNP
production in the heart, is an additional factor
contributing to heart failure. According to the results
of our study and previously published reports serum
BNP level has no diagnostic value in patients with
a right ventricle serving the systemic circulation or
common ventricle physiology. 
In conclusion, patients with a morphological right
ventricle serving the systemic circulation and with
common ventricle physiology after Fontana operation
show markedly reduced exercise capacity. They are
also characterized by higher serum concentrations
of BNP, which do not however correlate with
cardiopulmonary exercise test parameters.
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